References

Estimated projection of US cancer incidence and death to 2040

10.1001/jamanetworkopen.2021.4708 · 2021 · External reference

Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study

10.1038/s41416-022-01752-3 · 2022 · External reference

Unresolved reference

External reference

Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up

10.1016/j.annonc.2023.08.009 · 2023 · External reference

NCCN guidelines updates: pancreatic cancer

2019 · External reference

Pancreatic cancer

10.1016/s0140-6736(25)00261-2 · 2025 · External reference

Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial

10.1001/jama.2016.4324 · 2016 · External reference

Initial treatment and survival in 4163 Danish patients with pancreatic cancer: a nationwide unselected real-world register study

10.1016/j.ejca.2020.01.015 · 2020 · External reference

Benefit of chemoradiotherapy versus chemotherapy after induction therapy for conversion of unresectable into resectable pancreatic cancer: the randomized CONKO-007 trial

10.1200/jco-24-01502 · 2025 · External reference

Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy

10.1016/j.ijrobp.2011.09.008 · 2012 · External reference

Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer - A phase II study

10.1016/j.radonc.2024.110347 · 2024 · External reference

Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection

10.1097/sla.0000000000002753 · 2019 · External reference

One- and two-year overall survival following stereotactic body radiotherapy versus conventional radiotherapy for pancreatic cancer: a systematic review and meta-analysis

10.1097/js9.0000000000003992 · 2026 · External reference

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

10.1016/j.radonc.2004.12.022 · 2005 · External reference

UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy

10.1016/j.clon.2022.02.010 · 2022 · External reference

First clinical experiences with a high field 1.5 T MR linac

10.1080/0284186x.2019.1627417 · 2019 · External reference

Multi-institutional comparison of ablative 5-fraction magnetic resonance-guided online adaptive versus 15/25-fraction computed tomography-guided moderately hypofractionated offline adapted radiation therapy for locally advanced pancreatic cancer

10.3390/cancers17152596 · 2025 · External reference

Radiotherapy for locally advanced pancreatic adenocarcinoma-a critical review of randomised trials

10.3390/curroncol30070499 · 2023 · External reference

The use of MR-guided radiation therapy for pancreatic cancer

10.1016/j.semradonc.2023.10.002 · 2024 · External reference

A multi-institutional phase 2 trial of ablative 5-fraction stereotactic magnetic resonance-guided on-table adaptive radiation therapy for borderline resectable and locally advanced pancreatic cancer

10.1016/j.ijrobp.2023.05.023 · 2023 · External reference

Quality of life and toxicity in patients with pancreatic ductal adenocarcinoma treated with online adaptive stereotactic magnetic resonance guided radiation therapy

10.1016/j.ijrobp.2025.03.046 · 2025 · External reference

The MOMENTUM study: an international registry for the evidence-based introduction of MR-guided adaptive therapy

10.3389/fonc.2020.01328 · 2020 · External reference

Tumour motion analysis from planning to end of treatment course for a large cohort of peripheral lung SBRT targets

10.1080/0284186x.2021.1949036 · 2021 · External reference

Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: a global consensus protocol

2024 · External reference

Adaptive radiotherapy: the Elekta Unity MR-linac concept

2019 · External reference

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer

10.1016/j.radonc.2017.07.028 · 2017 · External reference

Balancing dose preservation and treatment efficiency in motion-managed magnetic resonance image-guided radiotherapy of pancreatic cancer

2026 · External reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

10.1016/j.ejca.2008.10.026 · 2009 · External reference

A note on quantifying follow-up in studies of failure time

10.1016/0197-2456(96)00075-x · 1996 · External reference

Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study

10.1016/j.radonc.2023.110064 · 2024 · External reference

Multi-institutional outcomes of patients aged 75 years and older with pancreatic ductal adenocarcinoma treated with 5-fraction ablative stereotactic magnetic resonance image-guided adaptive radiation therapy (A-SMART)

10.1177/10732748221150228 · 2023 · External reference

Stereotactic MR-guided adaptive radiotherapy for pancreatic tumors: updated results of the montpellier prospective registry study

10.3390/cancers15010007 · 2022 · External reference

Stereotactic ablative radiation for pancreatic cancer on a 1.5Telsa magnetic resonance-linac system

10.1016/j.phro.2022.10.003 · 2022 · External reference

Patterns of failure after definitive ablative 5-fraction stereotactic body radiation therapy for inoperable pancreatic ductal adenocarcinoma

2026 · External reference

Online adaptive radiotherapy: assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer

10.1016/j.radonc.2023.109869 · 2023 · External reference

Conventionally fractionated radiotherapy (CFRT) versus stereotactic body radiotherapy (SBRT) for locally advanced pancreatic cancer: a systematic review and meta-analysis of comparative studies

10.3390/cancers18060971 · 2026 · External reference